Vestibulodynia: Synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation

Journal of Lower Genital Tract Disease

Volumn 17, Issue 2, 2013, Pages 111-116

  Murina, Filippo ^a   Graziottin, Alessandra ^b   Felice, Raffaele ^a   Radici, Gianluigi ^a   Tognocchi, Cinzia ^c  

^a V BUZZI CHILDREN S HOSPITAL   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Midwife Private Gynecological Outpatients' Department   (Italy)

Author keywords

Palmitoylethanolamide; Transcutaneous electrical nerve stimulation; Transpolydatin; Vulvar vestibulitis syndrome; Vulvodynia

Indexed keywords

ANTIINFLAMMATORY AGENT; PALMIDROL; PLACEBO; TRANSPOLYDATIN; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; DYSPAREUNIA; ELECTRODE; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL CONDITION IMPROVEMENT; HOME CARE; HUMAN; MARINOFF SCORE; MAST CELL; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PERCEPTIVE THRESHOLD; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF CARE; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT DURATION; VISUAL ANALOG SCALE; VULVODYNIA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALGESICS; DRUG SYNERGISM; ENDOCANNABINOIDS; ETHANOLAMINES; FEMALE; GLUCOSIDES; HUMANS; MIDDLE AGED; PALMITIC ACIDS; PLACEBOS; STILBENES; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME; VULVODYNIA; YOUNG ADULT;

EID: 84876103452     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3182652316     Document Type: Article

References (29)

1. Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med 2004;49: 772-7.
2. Haefner HK, CollinsME, Davis GD, Edwards L, Foster DC, Hartmann ED, et al. The vulvodynia guideline. J Lower Gen Tract Dis 2005;9: 40-51.
3. Bohm-Starke N, Hilliges M, Falconer C, Rylander, E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1998;46: 256-60.
4. Tympanidis P, Terenghi G, Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 2003;148: 1021-7.
5. Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. GynecolObstet Invest 2004; 58: 171-8.
6. Pukall CF, Strigo IA, Binik YM, Amsel R, Khalife S, Bushnell MC. Neural correlates of painful genital touch in women with vulvar vestibulitis syndrome. Pain 2005;115: 118-27.
7. Groysman V. Vulvodynia: new concepts and review of the literature. Dermatol Clin 2010;28: 681-96.
8. Murina F, Bianco V, Radici G, Felice R, Di Martino M, Nicolini U. Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomized controlled trail. BJOG 2008;115: 1165-70.
9. Dionisi B, Anglana F, Inghirami P, Lippa P, Senatori R. Use of transcutaneous electrical stimulation and biofeedback for the treatment of vulvodynia (vulvar vestibular syndrome): result of 3 years of experience. MinervaGinecol 2008;60: 485-91.
10. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 2007;217: 65-78.
11. De Filippis D, Luongo L, Cipriano M, Palazzo E, Cinelli MP, de Novellis V, et al. Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Mol Pain 2011;7: 3.
12. Cerrato S, Brazis P, della Valle MF, Miolo A, Puigdemont A. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells. Vet Immunol Immunopathol 2010;133: 9-15.
13. Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med 1987;32: 110-4.
14. Marinoff SC, Turner MLC. Vulvar vestibulitis syndrome. Dermatol Clin 1992;10: 435-44.
15. Murina F, Bianco V, Radici G, Felice R, Signaroldi M. Electrodiagnostic functional sensory evaluation of patients with generalized vulvodynia: a pilot study. J Lower Gen Tract Dis 2010;14: 221-4.
16. Bornstein J, Cohen Y, Zarfati D, Sela S, Ophir E. Involvement of heparanase in the pathogenesis of localized vulvodynia, Int J Gynecol Pathol 2008;27: 136-41.
17. Graziottin A, Murina F. Clinical Management of VulvodyniaVTips and Tricks. Milan: Springer-Verlag; 2011: 61-2.
18. Miyamoto T, Dubin AE, Petrus MJ, Patapoutian A. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One 2009;4:e7596.
19. Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, Fuggetta MP. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 2012;35: 240-8.
20. Bohm-Starke N, Falconer C, Rylander E, Hilliges M. The expression of cyclooxygenase 2 and inducible nitric oxide synthase indicates no active inflammation in vulvar vestibulitis. Acta Obstet Gynecol Scand 2001;80: 638-44.
21. Rylander E, Berglund AL, Krassny C, Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect 2004;80: 54-7.
22. Babula O, Danielsson I, Sjoberg I, Ledger WJ, Witkin SS. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2004;191: 762-6.
23. Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Interleukin-1beta polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol 2003;107: 74-7.
24. Peters K, Girdler B, Carrico D, Ibrahim I, Diokno A. Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation. Int Urogynecol J Pelvic Floor Dysfunct 2008;19: 665-9.
25. Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007;105: 838-47.
26. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150: 971-9.
27. Chung JM, Fang ZR, Hori Y, Lee KH, Willis WD. Prolonged inhibition of primate spinothalamic tract cells by peripheral nerve stimulation. Pain 1984;19: 259-75.
28. Reed BD, Caron AM, Gorenflo DW, Haefner HK. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Lower Gen Tract Dis 2006;10: 245-51.
29. Glazer HI. Dysesthetic vulvodynia. Long-term followup after treatment with surface electromyography-assisted pelvic floor muscle rehabilitation. J Reprod Med 2000;45: 798-802.